Neurotrack develops digital cognitive health screening solutions to reduce the risk of Alzheimer's and related dementias.
Neurotrack has raised $10.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2022.
Neurotrack's investors include Founders Fund, Khosla Ventures, Sozo Ventures, Rethink Impact, Rock Health Capital.
Neurotrack is headquartered in Redwood City, United States.
Neurotrack develops digital cognitive health screening solutions to reduce the risk of Alzheimer's and related dementias.
Neurotrack is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neurotrack — Funding & Investors." VCBacked, November 1, 2022, https://www.vcbacked.co/company/neurotrack. Accessed September 30, 2026.
VCBacked. (2022). Neurotrack — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/neurotrack
{{cite web |title=Neurotrack — Funding & Investors |url=https://www.vcbacked.co/company/neurotrack |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated